Cita APA

Gwag, T., Meng, Z., Sui, Y., Helsley, R. N., Park, S., Wang, S., . . . Zhou, C. (2019). Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis. J Hepatol.

Chicago Style Citation

Gwag, Taesik, Zhaojie Meng, Yipeng Sui, Robert N. Helsley, Se-Hyung Park, Shuxia Wang, Richard N. Greenberg, i Changcheng Zhou. "Non-nucleoside Reverse Transcriptase Inhibitor Efavirenz Activates PXR to Induce Hypercholesterolemia and Hepatic Steatosis." J Hepatol 2019.

Cita MLA

Gwag, Taesik, et al. "Non-nucleoside Reverse Transcriptase Inhibitor Efavirenz Activates PXR to Induce Hypercholesterolemia and Hepatic Steatosis." J Hepatol 2019.